HCWB (HCW Biologics) Other Operating Expense: $0.43 Mil (TTM As of Mar. 2026)


HCWB HCW Biologics Inc HCWB
39 GF Score
Price $4.43
GF Value $43.77
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is HCW Biologics Other Operating Expense?

HCW Biologics HCWB -0.23% 39 Other Operating Expense is $0.43 Mil as of Mar. 2026. GuruFocus rates HCWB with a GF Score™ of 39/100 and a GF Value™ of $43.77 (Possible Value Trap). The stock has 7 warning signs investors should review.

HCW Biologics's Other Operating Expense for the three months ended in Mar. 2026 was $0.25 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.43 Mil.

HCW Biologics's quarterly Other Operating Expense declined from Sep. 2025 ($0.06 Mil) to Dec. 2025 ($0.06 Mil) but then increased from Dec. 2025 ($0.06 Mil) to Mar. 2026 ($0.25 Mil).

HCW Biologics's annual Other Operating Expense declined from Dec. 2023 ($5.52 Mil) to Dec. 2024 ($0.25 Mil) and declined from Dec. 2024 ($0.25 Mil) to Dec. 2025 ($0.24 Mil).

HCW Biologics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for HCW Biologics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCW Biologics Other Operating Expense Chart

HCW Biologics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 0.22 0.34 5.52 0.25 0.24

HCW Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.06 0.06 0.25
HCWB
39GF Score
HCW Biologics Inc HCWB
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCW Biologics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.43 Mil mean?
HCW Biologics (HCWB) has a Other Operating Expense of $0.43 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on HCW Biologics and its competitors.
Is HCW Biologics' Other Operating Expense too high?
HCW Biologics' current Other Operating Expense is $0.43 Mil. Overall, HCW Biologics has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does HCW Biologics' Other Operating Expense compare to KAPA and IMNN?
HCW Biologics' Other Operating Expense of $0.43 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on HCW Biologics and its competitors. HCW Biologics's current Other Operating Expense is $0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCW Biologics stock overvalued right now?
Based on GuruFocus' analysis, HCW Biologics (HCWB) is currently considered Possible Value Trap. The stock's GF Value™ is $43.77, compared to a current price of $4.43 — trading 89.9% below its estimated fair value. The current Other Operating Expense is $0.43 Mil. HCW Biologics' overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For HCW Biologics (HCWB), the current Other Operating Expense is $0.43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCW Biologics (HCWB) Overvalued in 2026?

Based on GuruFocus' analysis, HCW Biologics stock appears to be undervalued. The current stock price of $4.43 is trading 89.9% below its estimated GF Value™ of $43.77. GuruFocus considers HCW Biologics to be Possible Value Trap.

Key valuation signals for HCWB:

  • Other Operating Expense: $0.43 Mil
  • GF Value™: $43.77 vs. price of $4.43 (89.9% below fair value)
  • GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the HCWB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCW Biologics Business Description

Address 2929 N. Commerce Parkway, Miramar, FL, USA, 33025
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
39GF Score

Get the complete analysis for HCWB

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.43
Price
$43.77
GF Value